TMCI 株価推移チャート
TMCI 収入
Treace Medical Concepts, Inc
$2.66
-3.97%
$-0.1
終値： May 15, 16:00:00 GMT-4
$2.66
0%
$0
アフターマーケット：May 15, 20:00:00 GMT-4
戻る
Treace Medical Concepts, Inc (TMCI) 収入
最新の利益結果: Q1 '26
報告済み: 2026-05-08
歴史的収益
四半期
年次
EPS
収入
Earnings FAQ
TMCIの最近の1株当たり利益（EPS）は予想と比較してどうでしたか？
Treace Medical Concepts, Inc TMCIの前四半期の収益はどうでしたか？
Treace Medical Concepts, Incの収益見積もりはいくらですか？
Treace Medical Concepts, Incの収益品質スコアはどれくらいですか？
Treace Medical Concepts, Incはいつ収益を報告しますか？
Treace Medical Concepts, Incの予想収益はいくらですか？
Treace Medical Concepts, Incは収益予想を上回りましたか？
主要データ
前終値
$2.77
始値
$2.85
当日レンジ
$2.61 - $2.94
52週レンジ
$1.17 - $7.78
取引高
983.7K
平均取引高
776.2K
配当利回り
--
1株当たり利益(TTM)
-0.93
時価総額
$172.3M
TMCIとは何ですか？
Treace Medical Concepts, Inc. engages in the design, manufacture, and marketing of orthopedic medical devices and biologic solutions. The company is headquartered in Ponte Vedra, Florida and currently employs 450 full-time employees. The company went IPO on 2021-04-23. The company is advancing the standard of care for the surgical management of bunion and related midfoot deformities. The company has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. The company has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of midfoot deformities, the SpeedMTP Rapid Compression Implant for addressing bunions through big toe joint fusions, and two systems for minimally invasive osteotomy surgeries: the Nanoplasty 3D Minimally Invasive Bunion Correction System and the Percuplasty Percutaneous 3D Bunion Correction System. The company sells its products to physicians, surgeons, ambulatory surgery centers, hospitals, and stocking distributors.
